• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

HLA-E 递呈表位的发现:MHC-E/肽结合和 T 细胞识别。

Discovery of HLA-E-Presented Epitopes: MHC-E/Peptide Binding and T-Cell Recognition.

机构信息

Department of Infectious Diseases, Leiden University Medical Center, Leiden, The Netherlands.

Nuffield Department of Medicine Research Building, Old Road Campus, Roosevelt Drive, Nuffield Department of Medicine, University of Oxford, Oxford, UK.

出版信息

Methods Mol Biol. 2022;2574:15-30. doi: 10.1007/978-1-0716-2712-9_2.

DOI:10.1007/978-1-0716-2712-9_2
PMID:36087196
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10508831/
Abstract

Understanding the interactions involved during the immunological synapse between peptide, HLA-E molecules, and TCR is crucial to effectively target protective HLA-E-restricted T-cell responses in humans. Here we describe three techniques based on the generation of MHC-E/peptide complexes (MHC-E generically includes HLA-E-like molecules in human and nonhuman species, while HLA-E specifically refers to human molecules), which allow to investigate MHC-E/peptide binding at the molecular level through binding assays and by using peptide loaded HLA-E tetramers, to detect, isolate, and study peptide-specific HLA-E-restricted human T-cells.

摘要

了解免疫突触中肽、HLA-E 分子和 TCR 之间的相互作用对于有效地靶向人类保护性 HLA-E 限制的 T 细胞反应至关重要。在这里,我们描述了三种基于 MHC-E/肽复合物生成的技术(MHC-E 通常包括人类和非人类物种中的 HLA-E 样分子,而 HLA-E 则专门指人类分子),这些技术允许通过结合测定和使用负载肽的 HLA-E 四聚体在分子水平上研究 MHC-E/肽结合,以检测、分离和研究肽特异性 HLA-E 限制的人类 T 细胞。

相似文献

1
Discovery of HLA-E-Presented Epitopes: MHC-E/Peptide Binding and T-Cell Recognition.HLA-E 递呈表位的发现:MHC-E/肽结合和 T 细胞识别。
Methods Mol Biol. 2022;2574:15-30. doi: 10.1007/978-1-0716-2712-9_2.
2
Elucidating the immunological effects of 5-azacytidine treatment in patients with myelodysplastic syndrome and identifying new conditional ligands and T-cell epitopes of relevance in melanoma.阐明5-氮杂胞苷治疗骨髓增生异常综合征患者的免疫效应,并鉴定黑色素瘤中相关的新条件配体和T细胞表位。
Dan Med J. 2015 Aug;62(8):B5144.
3
A conserved energetic footprint underpins recognition of human leukocyte antigen-E by two distinct αβ T cell receptors.一种保守的能量足迹为两种不同的 αβ T 细胞受体识别人类白细胞抗原-E 提供了基础。
J Biol Chem. 2017 Dec 22;292(51):21149-21158. doi: 10.1074/jbc.M117.807719. Epub 2017 Sep 25.
4
Extensive major histocompatibility complex class I binding promiscuity for Mycobacterium tuberculosis TB10.4 peptides and immune dominance of human leucocyte antigen (HLA)-B*0702 and HLA-B*0801 alleles in TB10.4 CD8 T-cell responses.广泛的主要组织相容性复合物 I 类结合混杂性用于结核分枝杆菌 TB10.4 肽,以及人类白细胞抗原 (HLA)-B*0702 和 HLA-B*0801 等位基因在 TB10.4 CD8 T 细胞反应中的免疫优势。
Immunology. 2010 Apr;129(4):496-505. doi: 10.1111/j.1365-2567.2009.03201.x. Epub 2009 Nov 25.
5
[MHC tetramers: tracking specific immunity].[MHC四聚体:追踪特异性免疫]
Acta Med Croatica. 2003;57(4):255-9.
6
Structural analysis of two HLA-DR-presented autoantigenic epitopes: crucial role of peripheral but not central peptide residues for T-cell receptor recognition.两种HLA-DR呈递的自身抗原表位的结构分析:外周而非中央肽残基在T细胞受体识别中的关键作用
Mol Immunol. 2000 Oct;37(14):813-25. doi: 10.1016/s0161-5890(00)00109-7.
7
Identification of MHC class II restricted T-cell-mediated reactivity against MHC class I binding Mycobacterium tuberculosis peptides.鉴定 MHC Ⅱ类限制的 T 细胞对 MHC Ⅰ类结合结核分枝杆菌肽的反应性。
Immunology. 2011 Apr;132(4):482-91. doi: 10.1111/j.1365-2567.2010.03383.x. Epub 2011 Feb 7.
8
Class I-restricted alloreactive cytotoxic T lymphocytes recognize a complex array of specific MHC-associated peptides.I类限制性同种异体反应性细胞毒性T淋巴细胞识别一系列复杂的特定MHC相关肽。
J Immunol. 1998 Feb 1;160(3):1091-7.
9
A recombinant single-chain human class II MHC molecule (HLA-DR1) as a covalently linked heterotrimer of alpha chain, beta chain, and antigenic peptide, with immunogenicity in vitro and reduced affinity for bacterial superantigens.一种重组单链人II类主要组织相容性复合体分子(HLA-DR1),作为α链、β链和抗原肽的共价连接异源三聚体,在体外具有免疫原性,且对细菌超抗原的亲和力降低。
Eur J Immunol. 1997 Aug;27(8):1933-41. doi: 10.1002/eji.1830270817.
10
Conserved MHC class I peptide binding motif between humans and rhesus macaques.人类与恒河猴之间保守的MHC I类肽结合基序。
J Immunol. 2000 Jan 1;164(1):283-91. doi: 10.4049/jimmunol.164.1.283.

引用本文的文献

1
Targeting MHC-E as a new strategy for vaccines and immunotherapeutics.将MHC-E作为疫苗和免疫疗法的新策略。
Nat Rev Immunol. 2025 Sep 3. doi: 10.1038/s41577-025-01218-6.
2
HLA-E/peptide complexes differentially interact with NKG2A/CD94 and T cell receptors.HLA-E/肽复合物与NKG2A/CD94和T细胞受体存在差异相互作用。
J Immunol. 2025 Apr 1;214(4):595-605. doi: 10.1093/jimmun/vkae068.
3
Cancer vaccines compensate for the insufficient induction of protective tumor-specific immunity of CD3 bispecific antibody therapy.癌症疫苗弥补了CD3双特异性抗体疗法诱导保护性肿瘤特异性免疫不足的问题。

本文引用的文献

1
HLA-E-restricted, Gag-specific CD8 T cells can suppress HIV-1 infection, offering vaccine opportunities.HLA-E 限制的、Gag 特异性的 CD8 T 细胞可以抑制 HIV-1 感染,为疫苗提供了机会。
Sci Immunol. 2021 Mar 25;6(57). doi: 10.1126/sciimmunol.abg1703.
2
HLA-E typing of more than 2.5 million potential hematopoietic stem cell donors: Methods and population-specific allele frequencies.对超过 250 万潜在造血干细胞供体进行 HLA-E 分型:方法和人群特异性等位基因频率。
Hum Immunol. 2021 Jul;82(7):541-547. doi: 10.1016/j.humimm.2020.12.008. Epub 2020 Dec 30.
3
Peptide Binding to HLA-E Molecules in Humans, Nonhuman Primates, and Mice Reveals Unique Binding Peptides but Remarkably Conserved Anchor Residues.
J Immunother Cancer. 2025 Jan 11;13(1):e010331. doi: 10.1136/jitc-2024-010331.
4
HLA-E/ specific CD4 and CD8 T cells have a memory phenotype in individuals with TB infection.在结核病感染个体中,HLA-E特异性CD4和CD8 T细胞具有记忆表型。
Front Immunol. 2024 Dec 23;15:1505329. doi: 10.3389/fimmu.2024.1505329. eCollection 2024.
5
specific HLA-E restricted T cells are induced during infection but not after BCG administration in non-human primates and humans.在非人灵长类动物和人类中,特异性HLA-E限制性T细胞在感染期间而非卡介苗接种后被诱导产生。
bioRxiv. 2024 Aug 26:2024.08.26.609630. doi: 10.1101/2024.08.26.609630.
6
HLA-E-tetramer-sorted CD8 T cells have a diverse TCR repertoire.HLA-E四聚体分选的CD8 T细胞具有多样化的TCR库。
iScience. 2024 Feb 15;27(3):109233. doi: 10.1016/j.isci.2024.109233. eCollection 2024 Mar 15.
7
Neutralizing Antibodies Impair the Oncolytic Efficacy of Reovirus but Permit Effective Combination with T cell-Based Immunotherapies.中和抗体削弱了呼肠孤病毒的溶瘤效力,但允许与基于 T 细胞的免疫疗法有效联合。
Cancer Immunol Res. 2024 Mar 4;12(3):334-349. doi: 10.1158/2326-6066.CIR-23-0480.
8
Human leukocyte antigen and tumor immunotherapy (Review).人类白细胞抗原与肿瘤免疫治疗(综述)。
Int J Oncol. 2023 Jun;62(6). doi: 10.3892/ijo.2023.5516. Epub 2023 Apr 28.
肽与人、非人灵长类和小鼠 HLA-E 分子的结合揭示了独特的结合肽,但锚定残基惊人地保守。
J Immunol. 2020 Nov 15;205(10):2861-2872. doi: 10.4049/jimmunol.2000810. Epub 2020 Oct 5.
4
Detailed and atypical HLA-E peptide binding motifs revealed by a novel peptide exchange binding assay.通过新型肽交换结合测定法揭示详细且非典型的 HLA-E 肽结合基序。
Eur J Immunol. 2020 Dec;50(12):2075-2091. doi: 10.1002/eji.202048719. Epub 2020 Aug 17.
5
Mobilizing unconventional T cells.调动非常规T细胞。
Science. 2019 Oct 18;366(6463):302-303. doi: 10.1126/science.aay7079.
6
Production and Thermal Exchange of Conditional Peptide-MHC I Multimers.条件性肽-MHC I多聚体的产生与热交换
Curr Protoc Immunol. 2019 Sep;126(1):e85. doi: 10.1002/cpim.85.
7
Pathogen-derived HLA-E bound epitopes reveal broad primary anchor pocket tolerability and conformationally malleable peptide binding.病原体衍生的 HLA-E 结合表位揭示了广泛的主要锚定口袋耐受性和构象可变形的肽结合。
Nat Commun. 2018 Aug 7;9(1):3137. doi: 10.1038/s41467-018-05459-z.
8
The Role of MHC-E in T Cell Immunity Is Conserved among Humans, Rhesus Macaques, and Cynomolgus Macaques.MHC-E在人类、恒河猴和食蟹猴的T细胞免疫中的作用是保守的。
J Immunol. 2018 Jan 1;200(1):49-60. doi: 10.4049/jimmunol.1700841. Epub 2017 Nov 17.
9
Detailed characterization of human Mycobacterium tuberculosis specific HLA-E restricted CD8 T cells.详细描述人类结核分枝杆菌特异性 HLA-E 限制性 CD8 T 细胞。
Eur J Immunol. 2018 Feb;48(2):293-305. doi: 10.1002/eji.201747184. Epub 2017 Dec 15.
10
Crystal structure of Qa-1a with bound Qa-1 determinant modifier peptide.与结合的Qa-1决定簇修饰肽结合的Qa-1a晶体结构。
PLoS One. 2017 Aug 2;12(8):e0182296. doi: 10.1371/journal.pone.0182296. eCollection 2017.